FDA – Page 5 – medicarereport.org

Friday, September 11, 2026

Latest:

FDA Health Care Redesign Medicaid Medicare - General Part D/Prescription Drugs

Eileen Cook November 22, 2024November 22, 2024 Canadian Drug Import, Drug Industry, FDA, Lower Drug Costs, Medicaid, medicare

Florida Gov. DeSantis’ Canadian Drug Import Plan Goes Nowhere After FDA Approval

(By Phil Galewitz for KFF Health News) Nearly a year after the Biden administration gave Florida the green light to

FDA Part D/Prescription Drugs

Eileen Cook November 7, 2024November 7, 2024 FDA, GLP-1 drugs, Mounjaro, Ozempic

FDA adds warning to Ozempic, Mounjaro and other GLP-1 labels

(By Alexandra Murphy for Becker’s Hospital Review ) The FDA has updated the labels for all GLP-1 receptor agonists, including

FDA Medical Technology Pandemic

Eileen Cook November 5, 2024November 5, 2024 COVID-19 Pandemic, FDA, Healthcare Supply Chain, Medical Supplies Shortages

Why hospitals still can’t get the supplies they need

(By Stefanie Asin for Becker’s Hospital Review ) During the COVID-19 pandemic, healthcare supply chain issues were complex and plentiful,

FDA Health Care Finance Part D/Prescription Drugs

Eileen Cook September 12, 2024September 12, 2024 Biosimilars drugs, FDA, Healthcare Finance, Humira, Medicare Part D

Optum joins CVS, Cigna in dropping Humira

(By Rylee Wilson for Becker’s Hospital Review ) Optum Rx will join the other major pharmacy benefit managers and exclude

FDA Health Care Finance Medicare - General Part D/Prescription Drugs

Eileen Cook September 9, 2024September 9, 2024 FDA, Healthcare Costs, Healthcare Finance, medicare, Medicare Part D, TV Drug Ads

With TV Drug Ads, What You See Is Not Necessarily What You Get

(By Elisabeth Rosenthal for KFF Health News) Triumphant music plays as cancer patients go camping, do some gardening, and watch

Emerging Health Issues FDA Part D/Prescription Drugs

Eileen Cook September 4, 2024September 4, 2024 Drug Shortages, FDA, Medicare Part D

6 drugs now in shortage

(By Paige Twenter for Becker’s Hospital Review) The sole suppliers for a few medications, including a Parkinson’s disease therapy, are

CMS FDA Health Care Finance Health Care Redesign HHS Part D/Prescription Drugs

Eileen Cook August 21, 2024August 21, 2024 CMS, Healthcare Costs, Healthcare Finance, Inflation Reduction Act of 2022, medicare, Medicare Drug Price Negotiation Program, Medicare Part D, Older Adults

FAQs about the Inflation Reduction Act’s Medicare Drug Price Negotiation Program

(By Juliette Cubanski for The Kaiser Family Foundation Published: Aug 20, 2024) The Inflation Reduction Act of 2022 (the Act),

FDA Part D/Prescription Drugs

Eileen Cook August 19, 2024August 19, 2024 Drug Shortages, FDA, Medicare Part D

5 drugs now in shortage

(By Paige Twenter for Becker’s Hospital Review ) About two-thirds of providers recently told Premier their teams are spending more

FDA Medical Technology

Eileen Cook August 15, 2024August 15, 2024 FDA, Medical devices, Recalls

The FDA Calls Them ‘Recalls,’ Yet the Targeted Medical Devices Often Remain in Use

(By David Hilzenrath for KFF Health News) In 2016, medical device giant Abbott issued a recall for its MitraClip cardiac

FDA Part D/Prescription Drugs

Eileen Cook August 12, 2024August 12, 2024 Cancer Drugs, FDA, Krazati, Misleading claims

FDA calls out Bristol Myers over cancer drug claims

(By Elizabeth Gregerson for Becker’s Hospital Review ) The FDA has accused pharmaceutical company Bristol Myers Squibb of making false